Variation in the gene for one of the receptors for the hormone vasopressin appears to be associated with how human males bond with their partners, according to an international team of researchers.

The researchers found that the "334" allele of a common AVPR1A variation, the human version of avpr1a studied in voles, seemed to have negative effects on men's relationship with their spouses.

"Our findings are particularly interesting because they show that men who are in a relatively stable relationship of five years of more who have one or two copies of allele 334 appear to be less bonded to their partners than men with other forms of this gene," says Jenae Neiderhiser, professor of psychology, Penn State. "We also found that the female partners of men with one or two copies of allele 334 reported less affection, consensus and cohesion in the marriage, but interestingly, did not report lower levels of marital satisfaction than women whose male partners had no copies of allele 334."

Being an athlete or merely a fan improves language skills when it comes to discussing their sport because parts of the brain usually involved in playing sports are instead used to understand sport language, new research at the University of Chicago shows.

The research was conducted on hockey players, fans, and people who'd never seen or played the game. It shows, for the first time, that a region of the brain usually associated with planning and controlling actions is activated when players and fans listen to conversations about their sport. The brain boost helps athletes and fans understanding of information about their sport, even though at the time when people are listening to this sport language they have no intention to act.

LHC Kritiks in Switzerland, Germany and Austria survived the first ruling on their case by the European Court for Human Rights, August 29th. So did CERN's Large Hadron Collider, which will go ahead while the court action continues. A stunningly quick decision by the ECHR only 3 days after the complaint was filed against CERN and its 20 member countries from the EC denies any Interim Measures that would have forced CERN to suspend operations of the LHC.

Soon to be the world's most powerful atom smasher and the biggest and most costly science experiment ever, the $10 billion LHC straddles the borders of Switzerland and France, near Geneva. CERN, the giant European nuclear physics lab, has completed the 17 mile underground construction of the ring accelerator and is now in the first stages of start-up. It's goal is to unlock the secrets of the early Universe, through unparalled high energy collisions of hadrons, protons at first and then heavy lead ions. Critics believe that the LHC could pose enormous dangers to the planet.

Older age among fathers may be associated with an increased risk for bipolar disorder in their offspring, according to a report in the September issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

Bipolar disorder is a common, severe mood disorder involving episodes of mania and depression, according to background information in the article. Other than a family history of psychotic disorders, few risk factors for the condition have been identified. Older paternal age has previously been associated with a higher risk of complex neurodevelopmental disorders, including schizophrenia and autism.

WASHINGTON, September 1 /PRNewswire/ --

- One-Year Data Find Angioplasty and Stenting Safe and Effective in Patients for Whom Standard Therapy Has Been Open-Heart Surgery

Data announced today from the landmark SYNTAX trial indicate that patients with very complex coronary artery disease can safely choose to be treated with angioplasty and drug-eluting stents rather than open-heart surgery, says The Society for Cardiovascular Angiography and Interventions (SCAI). The one-year results of SYNTAX also show that most patients with left main and multi-vessel disease who undergo angioplasty and stenting will not need a second revascularization procedure in the first year.

GREENWICH, England, September 1 /PRNewswire/ --

WASHINGTON, September 1 /PRNewswire/ --

- At One Year, Angioplasty and Stenting Matches Bypass Surgery for Safety and Effectiveness in Patients with Complex Medical Condition

Patients with both diabetes and advanced blockages in at least three heart vessels will find good news in new findings announced today from the CARDia trial, says The Society for Cardiovascular Angiography and Interventions (SCAI). The one-year findings of the new study indicate that these patients can safely choose to undergo angioplasty and stenting rather than open-heart surgery.

BERLIN, September 1 /PRNewswire/ --

- Henning Ogberg Appointed New Vice President Sales - eleven Opens New Office in Munich

eleven, Germany's leading integrated e-mail security solutions provider, is expanding its sales activities in Germany and Europe and planning to enter markets in other regions. eleven has engaged Henning Ogberg as its new Vice President Sales to head up the newly opened eleven office in Munich and coordinate the market expansion starting September 1, 2008. The market expansion's purpose is to cement eleven's market leader status in Germany and build a strong presence in other markets in Europe and around the world.

MUNICH, Germany, September 1 /PRNewswire/ -- Biosensors International Group, Ltd ("Biosensors", "Company"), (Bloomberg: BIG:SP), (Singapore:B20) today announced that a next-generation drug-eluting stent, developed by Biosensors, has demonstrated equal safety and efficacy as compared to Johnson & Johnson's industry leading drug-eluting stent, CYPHER SELECT(TM) ("Cypher"), based upon nine-month clinical and angiographic follow-up data. The results of the landmark study were presented today at the 2008 European Society of Cardiology Congress and published concurrently on-line by the prestigious UK medical journal The Lancet.